科研製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2018/02/21 | 6,090 | 6,130 | 6,030 | 6,070 | -110 | -1.8% | 220,700 |
| 2018/02/20 | 6,150 | 6,260 | 6,130 | 6,180 | -10 | -0.2% | 180,400 |
| 2018/02/19 | 6,190 | 6,370 | 6,120 | 6,190 | +70 | +1.1% | 231,200 |
| 2018/02/16 | 5,840 | 6,120 | 5,840 | 6,120 | +570 | +10.3% | 630,200 |
| 2018/02/15 | 5,630 | 5,630 | 5,530 | 5,550 | -30 | -0.5% | 90,000 |
| 2018/02/14 | 5,540 | 5,620 | 5,540 | 5,580 | +80 | +1.5% | 150,400 |
| 2018/02/13 | 5,640 | 5,650 | 5,500 | 5,500 | -130 | -2.3% | 108,000 |
| 2018/02/09 | 5,500 | 5,640 | 5,500 | 5,630 | -30 | -0.5% | 154,300 |
| 2018/02/08 | 5,600 | 5,680 | 5,600 | 5,660 | +70 | +1.3% | 108,800 |
| 2018/02/07 | 5,600 | 5,730 | 5,590 | 5,590 | +90 | +1.6% | 145,600 |
| 2018/02/06 | 5,600 | 5,610 | 5,430 | 5,500 | -220 | -3.8% | 207,400 |
| 2018/02/05 | 5,810 | 5,830 | 5,710 | 5,720 | -190 | -3.2% | 151,500 |
| 2018/02/02 | 5,840 | 5,950 | 5,800 | 5,910 | +60 | +1% | 166,600 |
| 2018/02/01 | 5,720 | 5,960 | 5,720 | 5,850 | +130 | +2.3% | 241,300 |
| 2018/01/31 | 5,770 | 5,790 | 5,710 | 5,720 | -90 | -1.5% | 110,600 |
| 2018/01/30 | 5,870 | 5,890 | 5,770 | 5,810 | -70 | -1.2% | 168,100 |
| 2018/01/29 | 5,910 | 5,910 | 5,830 | 5,880 | -30 | -0.5% | 112,600 |
| 2018/01/26 | 5,950 | 5,980 | 5,900 | 5,910 | +10 | +0.2% | 119,600 |
| 2018/01/25 | 5,940 | 5,950 | 5,880 | 5,900 | -40 | -0.7% | 66,100 |
| 2018/01/24 | 5,870 | 5,950 | 5,860 | 5,940 | +70 | +1.2% | 107,100 |
| 2018/01/23 | 5,850 | 5,880 | 5,830 | 5,870 | +20 | +0.3% | 73,900 |
| 2018/01/22 | 5,780 | 5,850 | 5,760 | 5,850 | +120 | +2.1% | 104,900 |
| 2018/01/19 | 5,790 | 5,800 | 5,720 | 5,730 | +30 | +0.5% | 74,700 |
| 2018/01/18 | 5,810 | 5,840 | 5,680 | 5,700 | -10 | -0.2% | 212,000 |
| 2018/01/17 | 5,730 | 5,740 | 5,710 | 5,710 | -30 | -0.5% | 85,400 |
| 2018/01/16 | 5,760 | 5,780 | 5,720 | 5,740 | ±0 | ±0% | 47,600 |
| 2018/01/15 | 5,820 | 5,820 | 5,720 | 5,740 | -70 | -1.2% | 86,900 |
| 2018/01/12 | 5,830 | 5,840 | 5,790 | 5,810 | -40 | -0.7% | 104,300 |
| 2018/01/11 | 5,880 | 5,900 | 5,810 | 5,850 | -40 | -0.7% | 93,700 |
| 2018/01/10 | 5,910 | 5,920 | 5,860 | 5,890 | -10 | -0.2% | 89,300 |
| 2018/01/09 | 5,890 | 5,900 | 5,860 | 5,900 | +10 | +0.2% | 75,200 |
| 2018/01/05 | 5,880 | 5,900 | 5,820 | 5,890 | +10 | +0.2% | 134,200 |
| 2018/01/04 | 5,880 | 5,910 | 5,830 | 5,880 | +60 | +1% | 147,200 |
| 2017/12/29 | 5,720 | 5,840 | 5,690 | 5,820 | +120 | +2.1% | 169,700 |
| 2017/12/28 | 5,680 | 5,740 | 5,680 | 5,700 | -10 | -0.2% | 114,800 |
| 2017/12/27 | 5,840 | 5,860 | 5,680 | 5,710 | -240 | -4% | 296,200 |
| 2017/12/26 | 5,920 | 5,980 | 5,900 | 5,950 | +20 | +0.3% | 59,500 |
| 2017/12/25 | 5,930 | 5,940 | 5,890 | 5,930 | ±0 | ±0% | 54,000 |
| 2017/12/22 | 5,980 | 6,000 | 5,920 | 5,930 | -60 | -1% | 115,000 |
| 2017/12/21 | 5,970 | 6,000 | 5,930 | 5,990 | +30 | +0.5% | 149,500 |
| 2017/12/20 | 5,940 | 5,970 | 5,910 | 5,960 | +10 | +0.2% | 104,900 |
| 2017/12/19 | 5,910 | 5,950 | 5,900 | 5,950 | +50 | +0.8% | 134,100 |
| 2017/12/18 | 5,880 | 5,900 | 5,820 | 5,900 | +100 | +1.7% | 136,800 |
| 2017/12/15 | 5,870 | 5,870 | 5,780 | 5,800 | -40 | -0.7% | 80,700 |
| 2017/12/14 | 5,900 | 5,910 | 5,800 | 5,840 | -40 | -0.7% | 107,900 |
| 2017/12/13 | 5,850 | 5,940 | 5,820 | 5,880 | +60 | +1% | 164,100 |
| 2017/12/12 | 5,780 | 5,840 | 5,780 | 5,820 | +50 | +0.9% | 122,800 |
| 2017/12/11 | 5,760 | 5,780 | 5,720 | 5,770 | +50 | +0.9% | 108,400 |
| 2017/12/08 | 5,620 | 5,720 | 5,610 | 5,720 | +60 | +1.1% | 195,200 |
| 2017/12/07 | 5,600 | 5,680 | 5,600 | 5,660 | +100 | +1.8% | 97,800 |
1751～
1800
件表示中 / 3686件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 科研薬 | 413,300円 | +30.5% | +111.0% | 4.60% | 11.65倍 | 1.01倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| 日本新薬 | 361,300円 | +7.9% | +8.9% | 3.43% | 7.73倍 | 1.04倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| ペプチド | 188,000円 | +5.0% | +1.5% | 0.00% | 16.14倍 | 4.29倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| キッセイ薬 | 384,500円 | +14.5% | -2.3% | 2.34% | 14.07倍 | 0.75倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| サンバイオ | 208,800円 | - | - | 0.00% | - | 96.71倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム
